Quarterly Activity Report and Appendix C

Quarterly Activity Report – Period ending 30 June 2020 Q2 Highlights: Company announces plans for the Phase I first-in-human study to be undertaken in…


Proposed Issue of Securities — IBX

Imagion Biosystems Limited has announced a Proposed Issue of Securities. Read the Proposed Issue of Securities.


Proposed Issue of Securities — IBXOA

Imagion Biosystems has announced a Proposed Issue of Securities. Read the Proposed Issue of Securities.


IBX Raises $5M in Oversubscribed Placement

$5M raised in an oversubscribed placement at 4.5c per share – equivalent to 30 day VWAP, and a 33.9% premium to 60 day VWAP. Strongly supported by existing…